International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13368455
Original Research Article
Efficacy of Intracameral versus Topical Mydriatics in Phacoemulsification Surgery – A Randomized Controlled Trial
Published
Aug. 24, 2024
Abstract

Purpose: To compare the efficacy of an intracameralmydriatic agent with a topicalmydriatic eye drop during phacoemulsification cataract surgery.Methods: All the patients with age group between 40 to 80 years with immature senile cataract, who came to the Ophthalmology OPD & were posted for surgery, were randomized into two groups. One group received topical mydriatics (Group-A) & the other group received intracameralmydriatic (Group-B), for pupil dilation prior to surgery. Parameters compared among both the groups,werethe size of pupilat different time points during the surgery;the onset of action of mydriasis& mean changes of variation in the pulse rate, systolic & diastolic blood pressures, at various time points during the surgery.Result: A total of 204 patients were enrolled in this study, who were randomly divided among both the groups (102 each). In Group-A, it was observed that the mean pupil size was maximum at 30 minutes after the start of topical drug administration i.e.- (7.81 +/-1.03) mm.; which gradually decreased towards the end of surgery. Whereas, in Group-B, the pupil size measured during the same time was (7.45 +/-0.81) mm., which also decreased gradually towards the end of surgery. But, following nucleus removalfrom the anterior chamber &corticalaspiration, the mean pupil size in Group-B was observed to be (6.45 +/-0.91) mm., which was greater than that of Group-A, i.e.- (6.01 +/-0.70)mm. Also, the time duration for which the pupil was larger during the surgery was found to be better in Group-B, compared to Group-A. Moreover, blood pressure & pulse rate, measured during various time points during the surgery, were observed to be within the permissible limits in both the groups.Conclusion: Intracameralmydriasis is a rapid, safe & effective alternative for pupil dilatation, during cataract surgery, with lesser systemic side effects; compared to the traditional topical eye drops.

Recommended Articles
Loading Image...
Volume-5, Issue-4
Citations
2626 Views
38 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved